Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection

Chagas disease (CD), caused by Trypanosoma cruzi, affects approximately 6 to 7 million people in Latin America, with cardiomyopathy being the clinical manifestation most commonly associated with patient death during the acute phase. The etiological treatment of CD is restricted to benznidazole (Bz)...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbosa, Juliana Magalhães Chaves, Pedra Rezende, Yasmin, de Melo, Tatiana Galvão, de Oliveira, Gabriel, Cascabulho, Cynthia Machado, Pereira, Evelyn Nunes Goulart da Silva, Daliry, Anissa, Salem, Kelly Salomão
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826820/
https://www.ncbi.nlm.nih.gov/pubmed/35138142
http://dx.doi.org/10.1128/spectrum.01852-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826820/
https://www.ncbi.nlm.nih.gov/pubmed/35138142
http://dx.doi.org/10.1128/spectrum.01852-21

Ejemplares similares